Time-resolved luminescence detection of peroxynitrite using a reactivity-based lanthanide probe. by Breen,  Colum et al.
Durham Research Online
Deposited in DRO:
15 April 2020
Version of attached file:
Published Version
Peer-review status of attached file:
Peer-reviewed
Citation for published item:
Breen, Colum and Pal, Robert and Elsegood, Mark R. J. and Teat, Simon J. and Iza, Felipe and Wende,
Kristian and Buckley, Benjamin R. and Butler, Stephen J. (2020) 'Time-resolved luminescence detection of
peroxynitrite using a reactivity-based lanthanide probe.', Chemical science., 11 (12). pp. 3164-3170.
Further information on publisher's website:
https://doi.org/10.1039/C9SC06053G
Publisher's copyright statement:
This article is licensed under a Creative Commons Attribution 3.0 Unported Licence.
Additional information:
Use policy
The full-text may be used and/or reproduced, and given to third parties in any format or medium, without prior permission or charge, for
personal research or study, educational, or not-for-profit purposes provided that:
• a full bibliographic reference is made to the original source
• a link is made to the metadata record in DRO
• the full-text is not changed in any way
The full-text must not be sold in any format or medium without the formal permission of the copyright holders.
Please consult the full DRO policy for further details.
Durham University Library, Stockton Road, Durham DH1 3LY, United Kingdom
Tel : +44 (0)191 334 3042 | Fax : +44 (0)191 334 2971
http://dro.dur.ac.uk
Time-resolved luminescence detection of
peroxynitrite using a reactivity-based lanthanide
probe†
Colum Breen,a Robert Pal, b Mark R. J. Elsegood, a Simon J. Teat, c Felipe Iza,d
Kristian Wende, e Benjamin R. Buckley a and Stephen J. Butler *a
Peroxynitrite (ONOO) is a powerful and short-lived oxidant formed in vivo, which can react with most
biomolecules directly. To fully understand the roles of ONOO in cell biology, improved methods for the
selective detection and real-time analysis of ONOO are needed. We present a water-soluble,
luminescent europium(III) probe for the rapid and sensitive detection of peroxynitrite in human serum,
living cells and biological matrices. We have utilised the long luminescence lifetime of the probe to
measure ONOO in a time-resolved manner, effectively avoiding the influence of autofluorescence in
biological samples. To demonstrate the utility of the Eu(III) probe, we monitored the production of
ONOO in different cell lines, following treatment with a cold atmospheric plasma device commonly
used in the clinic for skin wound treatment.
Introduction
Peroxynitrite (ONOO) is a highly reactive nitrogen species
generated from the spontaneous reaction between superoxide
(O2
) and nitric oxide (NO). In cells, ONOO is generated
predominantly in the mitochondria and is involved in cellular
signalling processes, via nitration of tyrosine residues on
proteins and nitrosylation of protein thiols.1–4 In contrast,
elevated levels of ONOO can lead to signicant oxidative and
nitrosative damage to lipids, proteins and DNA and has been
implicated in several diseases including Alzheimer's, Hunting-
ton's, and Parkinson's disease.5–7 Therefore, ONOO has
become a very important target for detection in a cellular
environment.
The ability to detect ONOO selectively would facilitate
a better understanding of its roles in cellular biology, disease
diagnosis, and therapies based on redox signalling events (e.g.
photodynamic therapy and radiotherapy).8 In recent years, cold
atmospheric plasma (CAP) has emerged as a promising new
biomedical technology for the treatment of chronic wounds and
cancer (e.g. breast, skin, lung, and pancreatic cancer).9–11 The
therapeutic effects of CAP are linked to the high concentrations
of reactive oxygen and nitrogen species (RONS) generated by the
plasma.12
In chronic wound treatment, plasma generated NO and
ONOO are proposed to break down bacterial biolm by
interacting with the lipid membrane, forming pores that facil-
itate further RONS ingress.13,14 The selective killing of cancer
cells by plasma has been attributed to high levels of RONS (e.g.
NO, ONOO, H2O2), which exceeds the cancer cell's compro-
mised oxidative defence mechanisms.9 Despite the importance
of RONS in plasma-based cell therapy, very little is known about
the specic interactions between plasma and biological
samples. To elucidate the mechanisms that deliver plasma
generated RONS to cells and tissues, improved methods for the
precise measurement of specic RONS are needed.
Detecting ONOO is particularly difficult due to its very short
lifetime (10 ms) and propensity to react, forming longer-lived
species (NO3
). A traditional assay for ONOO detection
involves immunostaining of 3-nitrotyrosine;15 however, this
approach is not applicable for live-cell imaging studies. In
recent years, uorescent molecular probes have emerged as
attractive tools for imaging ONOO in a cellular environment. A
series of reactivity-based probes have been devised that signal
ONOO by a change in uorescence.16a–e Notwithstanding some
notable exceptions,16b,e the majority of existing ONOO probes
have limitations in performance, due to their lack of solubility
in 100% aqueous media, limited selectivity for ONOO over
other RONS (e.g. NO, hypochlorite, hydroxyl radicals), and
relatively slow response times, which prevents real-time
measurements. One major difficulty encountered with organic
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probes stems from their short-lived uorescence, which can be
difficult to distinguish from the background uorescence of
biomolecules, oen precluding accurate measurements of
ONOO.17
Luminescent lanthanide probes offer unique photophysical
advantages over classical organic uorescent probes,18,19
including: (1) long emission lifetimes that enable time-gated
and time-resolved measurements, thereby increasing preci-
sion and signal to noise;20,21 (2) well-dened emission bands
that may vary in intensity in response to specic analytes,
allowing quantitative analysis;22 and (3) large separations
between the absorption and emission spectra, which minimises
self-quenching processes. Several water-soluble lanthanide
complexes have been developed into effective cellular imaging
probes, which localise to specic subcellular compartments and
report on target species with high spatial and temporal reso-
lution.23,24 A few lanthanide probes have been developed to
detect ONOO;25,26 however, their sensing mechanisms rely
upon quenching of an excited state complex, involving charge
transfer with the electron rich ONOO. Such probes are limited
in cellular imaging applications because other electron rich
species present in the cell (e.g. urate, ascorbate) are known to
induce excited state quenching,27,28 and could also give rise to
the observed decrease in luminescence.
In this work, we report the design and synthesis of a water-
soluble, luminescent Eu(III) complex, Eu.1 (Fig. 1A) for the
time-resolved detection of ONOO in human blood serum and
living cells. The probe comprises a quinoline antenna func-
tionalised at the 8-position with a benzyl boronic acid, which
undergoes rapid oxidative cleavage in the presence of ONOO to
reveal an 8-hydroxyquinoline unit, which shuts down energy
transfer to the Eu(III) ion and switches off luminescence
(Fig. 1B). Eu.1 displays nanomolar sensitivity to ONOO and
provides a long-lived luminescence signal, which permits time-
resolved measurements of ONOO, completely eliminating
background autouorescence from the biological sample. To
demonstrate its utility in cellular applications, the probe was
used to quantify ONOO in different cell lines, following
treatment with a commercial plasma device, CAP jet kINPEN®
MED, clinically used to foster chronic and acute wound healing.
Results and discussion
Probe design, synthesis and characterisation
Probe Eu.1 is based on a nonadentate macrocyclic ligand, pos-
sessing a single coordinating quinoline group that acts as an
efficient sensitizer of Eu(III) emission. The quinoline unit binds
to the Eu(III) ion in a bidentate manner, effectively shielding the
metal centre from surrounding water molecules, thereby
enhancing the emission intensity and lifetime of Eu.1. The
probe is functionalised with a benzyl boronic acid group, which
we envisaged would react rapidly and selectively with ONOO,
causing oxidative cleavage to reveal an 8-hydroxyquinoline unit,
which prevents energy transfer to the Eu(III) ion and triggers
a decrease in time-resolved luminescence (Fig. 1B). The probe
exploits the considerably higher reactivity of phenyl boronic
acids towards ONOO (k z 106 M1 s1) at physiological pH,
compared with other RONS (e.g. H2O2, k z 2.2 M
1 s1).29 A
control complex, Eu.Bn (Fig. 1A), lacking the boronic acid
moiety, was synthesised to validate the response of Eu.1 towards
ONOO. Additionally, Eu.8HQ, the expected product of the
reaction between Eu.1 and ONOO, was synthesised to conrm
its lack of luminescence in water.
Full details of the synthesis of Eu.1, Eu.Bn and Eu.8HQ are
provided in the ESI.† Briey, Eu.1 was synthesised starting from
8-hydroxyquinoline-2-carboxaldehyde, which was O-alkylated
with 4-iodobenzyl bromide, followed by reduction of the alde-
hyde to the primary alcohol. Subsequent mesylation of the
methyl alcohol and alkylation onto a tert-butyl protected DO3A
gave the macrocyclic ligand, which was deprotected and com-
plexed with EuCl3. The Eu(III) complex was subjected to
a Miyaura borylation to provide Eu.1 aer purication by
reverse-phase HPLC.
Selected photophysical data for Eu.1, Eu.Bn, and Eu.8HQ are
provided in Table 1. The UV-Vis absorption spectra of Eu.1 and
Eu.Bn in water are similar and feature a broad band centred at
321 nm (Fig. 2A). In contrast, Eu.8HQ displays a signicantly
red-shied band centred at 384 nm (Fig. 2B), which may be
associated with a charge-transfer transition, involving transfer
of charge density from the quinoline oxygen atom to the quin-
oline unit.32 The emission properties of Eu.1 and Eu.8HQ in
buffered aqueous solution (100 mM PBS, pH 7.4) were very
different (Fig. 2). Eu.1 displayed signicant Eu(III) centred
luminescence with a quantum yield of 10% (lexc¼ 321 nm). The
emission spectrum is characterised by three components in the
DJ ¼ 1 band (585–605 nm), indicating a structure of low
symmetry, and a prominent DJ ¼ 2 (605–630 nm) band. In
contrast, Eu.8HQ was found to be very weakly emissive (fem <
0.5%) over the pH range 4–10 (Fig. 2B and S2†), when excited at
either 321 nm or 384 nm. The weak luminescence of Eu.8HQ
can be attributed to the low lying excited state of the 8-
hydroxyquinolinate group (around 17 100 cm1),33 and its
inability to effectively populate the Eu(III) excited state.34 The
Fig. 1 (A) Structure of Eu(III) probe Eu.1 and control complex Eu.Bn. (B)
Mechanism of detection of ONOO, based on oxidative cleavage of
the phenyl boronic acid group of Eu.1 to form non-emissive complex
Eu.8HQ.
This journal is © The Royal Society of Chemistry 2020 Chem. Sci., 2020, 11, 3164–3170 | 3165
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free ligand 8HQ is also nonuorescent (Fig. S3†), consistent
with efficient non-radiative decay of the 8-hydroxyquinoline
excited state, due to intermolecular proton transfer.35,36 In
support of this hypothesis, strong uorescence was observed for
the iodo-ligand precursor to Eu.1 (Fig. S3†), in which the benzyl
ether prevents non-radiative energy loss via a proton transfer
mechanism.
Eu.1 possesses a long luminescence lifetime in water (0.52
ms), which increases slightly in D2O (0.66 ms). The hydration
state (q value) of Eu.1 was calculated to be 0.2,30 indicating
a lack of coordinated water in the rst coordination sphere. This
was supported by synchrotron X-ray analysis of the crystal
structure of Eu.1 (Fig. 3; CCDC 1965719, see ESI† for further
details), grown from slow evaporation of an aqueous solution.
The Eu(III) ion is encapsulated by the nonadentate ligand in
a twisted square antiprismatic geometry, coordinated to four
nitrogen atoms from the macrocyclic ring, three oxygen atoms
from the carboxylate groups, one nitrogen from the quinoline
group and one axial oxygen atom from the quinoline 8-alkoxyl
group, inhibiting water access. The nearest water molecules are
over 6.5 A˚ away from the Eu(III) ion (Fig. S4†); such effective
shielding from water increases the luminescence of Eu.1, by
minimising deactivation of the Eu(III) excited state via energy
transfer to O–H vibrations. The structurally related complex,
Eu.Bn, has a hydration state close to zero, and is expected to
adopt a similar coordination geometry to that of Eu.1, in which
the benzyloxy group occupies the axial position, preventing
water binding.31 For Eu.8HQ, a q value of 0.5 was found, indi-
cating ‘partial hydration’ of the complex,30 in which a water
molecule is bound in the second hydration sphere, possibly
held by hydrogen bonds to the quinoline 8-hydroxyl group.
Evaluation of Eu.1 for selective detection of peroxynitrite
The ability of Eu.1 to detect peroxynitrite was evaluated in aqueous
buffer (100mMPBS pH 7.4). Addition of 1 equivalent of ONOO to
Eu.1 (25 mM) resulted in immediate and almost complete loss of
Eu(III) luminescence (Fig. 4A), consistent with rapid oxidative
cleavage of the benzyl boronic acid group and quantitative
formation of the weakly emissive complex Eu.8HQ. This was
conrmed by UV-Vis analysis of the reaction mixture, which
showed a characteristic red-shied band centred at 384 nm, and
LC-MS revealed a single peak with m/z ¼ 654.1 corresponding to
the single charged complex [Eu.8HQ + H]+ (Fig. S5†). The fast
sensing kinetics of Eu.1 is an important feature given the transient
nature of ONOO in biological systems.
In contrast, treatment of Eu.1 with 1 equivalent of H2O2 (25
mM), the longest-lived reactive species in cellulo,37 caused
a minor (approximately 5%) decrease in emission intensity
(Fig. S6†), and a much higher concentration of H2O2 (500 mM)
was required to induce a gradual 45% decrease in emission
intensity aer 20 minutes (Fig. 4A). Treatment of the control
complex Eu.Bn with ONOO or H2O2 under the same condi-
tions resulted in less than 15% change in emission intensity
and negligible changes in absorption spectra (Fig. S7†).
The high selectivity of Eu.1 for ONOO was demonstrated
fully by incubating the probe with a range of RONS (100 mM
HOc, NO, NO2
, NO3
, O2c
, 1O2), as well as common biological
cations (e.g. 1 mM Mg2+, Ca2+), anions (1 mM ATP, ADP bicar-
bonate, chloride) and biomolecules (e.g. BSA, glutathione)
(Fig. 4B). The only species that induced a signicant (>20%)
Table 1 Photophysical data for Eu(III) complexes (100 mM PBS, pH 7.4)
Complex lmax/nm 3/M
1 cm1 fem
a/% sH2O/ms sD2O/ms q
b
Eu.1 321 2800 10 0.52 0.66 0.2
Eu.8HQ 382 2100 <0.5 0.33 0.42 0.5
Eu.Bn 321 2600 (2560) 6 (6) 0.58 (0.37) 0.72 (0.44) 0.1 (0.2)
a Errors in quantum yields and lifetimes are15%. b Values of hydration state, q (20%) were derived using literature methods.30 Values for Eu.Bn
in parentheses were determined in water previously, by Williams.31
Fig. 2 Absorption and emission spectra of (A) Eu.1 (25 mM, lexc ¼
321 nm, lem¼ 550–720 nm); (B) Eu.8HQ (25 mM, lexc¼ 384 nm, lem¼
550–720 nm), measured in aqueous buffer (100 mM PBS, pH 7.4).
Fig. 3 X-ray crystal structure of Eu.1, revealing a lack of water in the
first coordination sphere of Eu(III).
3166 | Chem. Sci., 2020, 11, 3164–3170 This journal is © The Royal Society of Chemistry 2020
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change in luminescence of Eu.1 was hypochlorite (OCl);
addition of 50 mM OCl caused a 50% decrease in emission
intensity of Eu.1 (Fig. S9†). Considering that the concentration
of OCl in cells is estimated to be less than 1 mM,38 and that it
reacts rapidly with endogenous thioethers and amines (e.g.Met
¼ 3.8  107, His ¼ 1.0  105 M1 s1),39,40 it can be assumed
that OCl will not compete for Eu.1 in a cellular environment.
The sensitivity of Eu.1 towards ONOO was evaluated by
incubating the probe with different concentrations of ONOO
and recording the time-resolved emission intensity using
a plate reader. Pleasingly, the linear decrease in time-resolved
luminescence of Eu.1 can be used to detect ONOO in the
nanomolar concentration range (1–1000 nM) (Fig. 4D). The
probe is thus well suited for measuring steady state concen-
trations of intracellular ONOO, estimated to be in the nano-
molar range.41 Further, the dynamic range of ONOO detection
can be tuned by varying the concentration of Eu.1: incremental
addition of ONOO (1–25 mM) to Eu.1 (25 mM) provided a linear
calibration plot (Fig. 4C), suitable for the measurement of
micromolar levels of ONOO. Such levels may be generated in
experiments designed to administer reactive species to cells and
tissues (e.g. by using ionizing plasma).42–46
Time-resolved measurement of peroxynitrite in human serum
To further demonstrate the high sensitivity and selectivity of Eu.1
for ONOO, a competition experiment was undertaken in human
serum, containing excess H2O2. The time-resolved emission
response of Eu.1 towards ONOO, in the absence and presence of
500 mMH2O2, was essentially the same (Fig. 5A), revealing the ability
of Eu.1 to detect ONOO in biological media, in a background of
excess H2O2. Next, the production of ONOO
 in human serum was
monitored in real time, by incubating Eu.1 with 3-morpholino-
sydnonimine (SIN-1, 250 mM), which decomposes to release equi-
molar amounts of NO and O2c
, leading to spontaneous and
sustained production of ONOO (mimicking cellular ONOO
production). Incubation with SIN-1 caused a 75% reduction in time-
resolved luminescence of Eu.1 aer approximately 20 minutes
(Fig. 5B), corresponding to the formation of approximately 40 mM
ONOO, determined from the linear calibration plot (Fig. S8†).
Further, the simultaneous addition of SIN-1 and the superoxide
scavenger, TEMPO (2,2,6,6-tetramethylpiperidine-N-oxyl), resulted
in a signicantly smaller (25%) decrease in time-resolved emission
of Eu.1 over a 30 minute period (Fig. 5B), corresponding to the
formation of 10 mM ONOO under these conditions.
Cellular uptake and localisation studies
Having shown that Eu.1 can be used to measure the production
of micromolar levels of ONOO in human serum, by gating out
short-lived autouorescence from biological uorophores, we
next investigated the ability of Eu.1 to measure dynamic
changes in ONOO concentration in living cells. First, the
cellular uptake behaviour of Eu.1 in HeLa cells was evaluated
using uorescence and laser scanning confocal microscopy
(LSCM). Eu.1 (250 mM) was incubated in HeLa cells for 4 hours,
resulting in uptake of the Eu(III) complex and predominant
localisation to the mitochondria (lexc ¼ 355 nm, lem ¼ 605–720
nm), conrmed by colocalisation studies using MitoTracker
Green (lexc ¼ 488 nm, lem ¼ 500–530 nm), which gave a Pear-
son's coefficient, P ¼ 0.80 (Fig. 6A–C). The preferential distri-
bution of Eu.1 in the mitochondria augured well for the
detection of endogenous ONOO, because the precursor
species, NO and O2c
, react predominately in the mitochondria,
and we have previously demonstrated that these reactive species
do not interfere with the emission response of Eu.1 (Fig. 4B).
A time-lapsed series of images revealed maximum uptake
Eu.1 in HeLa cells aer 4 hours (Fig. S10A†). Imaging of Eu.1 in
Fig. 4 (A) Immediate and dramatic response of Eu.1 to ONOO (25
mM, red) compared with the gradual response to H2O2 (500 mM, black),
measured in 100mM PBS, pH 7.4 (lex¼ 321 nm); (B) selective response
of Eu.1 (25 mM) towards ONOO (25 mM), over other RONS including
100 mMHOc, NO, NO2
, NO3
, O2c
, 1O2, as well as biological analytes
(1 mM Cl, HCO3
, Ca2+, ATP, ADP, phosphate, glucose, fructose,
phosphoglucose, glutathione, cysteine, and BSA), recorded after 30
minute incubation in 100 mM PBS, pH 7.4 (lex ¼ 321 nm, lem ¼ 605–
630 nm); (C) calibration plot for the time-resolved detection of
micromolar (1–25 mM) ONOO using Eu.1 (25 mM); and (D) calibration
plot for the time-resolved detection of nanomolar (1–1000 nM)
ONOO using Eu.1 (5 mM) (lex ¼ 321, lem ¼ 605–630 nm, integration
time 60–400 ms).
Fig. 5 Time-resolved measurement of ONOO in human serum. (A)
Change in emission intensity of Eu.1 (50 mM) following incubation with
H2O2 (500 mM, red), ONOO
 (50 mM, blue), and ONOO plus H2O2 (50
mM and 500 mM respectively, grey). (B) Time-dependent change in
emission intensity of Eu.1 (50 mM) following incubation with 500 mM
SIN-1 (red), and SIN-1 plus 500 mMTEMPO (black), measured in human
serum (pH 7.0–7.4), lex ¼ 321, lem ¼ 605–630 nm, integration time
60–400 ms.
This journal is © The Royal Society of Chemistry 2020 Chem. Sci., 2020, 11, 3164–3170 | 3167
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the mitochondria was possible over extended time periods (up
to 40 hours), during which time the brightness of the observed
images did not vary signicantly (15%) and the cells appeared
to be healthy and growing. Analysis of ICP-MS data showed that
for 4  106 HeLa cells incubated with Eu.1 (250 mM), a given cell
contained 26 mM (10%) of Eu.1 (Fig. S10C†), hence the intra-
cellular concentration of the Eu(III) probe reaches 10% of the
loading buffer aer 4 hours. Cytotoxicity studies were under-
taken for Eu.1 at 24 hours using image cytometry assays
(involving DAPI and acridine orange stains), which showed an
IC50 value of greater than 250 mM (Fig. S10B†). Therefore, it can
be assumed that the Eu(III) probe did not exhibit cytotoxicity
during the timeframe of these imaging experiments.
Imaging changes in peroxynitrite levels in living cells
Next, HeLa cells stained with Eu.1 were incubated with the
ONOO donor, SIN-1, for 30 minutes. This resulted in a signif-
icant (approx. 90%) decrease in emission intensity (Fig. 6E),
indicating an increase in mitochondrial ONOO levels upon
SIN-1 stimulation. It is unlikely that any ONOO generated in
the cell culture medium will cross cell membranes;3,41 however,
the ability of NO to penetrate cell membranes is known. So, the
observed decrease in image brightness is consistent with SIN-1
mediated delivery of NO inside the cell, which combines with
superoxide in the mitochondria to form ONOO spontane-
ously.2 In contrast, incubation of Eu.1-stained cells with SIN-1
and the superoxide scavenger, TEMPO, induced a signicantly
smaller (35%) decrease in luminescence compared with
untreated cells (Fig. 6F), indicating reduced intracellular
formation of ONOO compared with the SIN-1 treatment alone.
The Eu(III) probe remained predominantly in the mito-
chondria during the time scale of the experiments. Further, ICP-
MS analysis of cells treated with SIN-1 (and SIN-1 plus TEMPO),
showed less than 10% variation in the concentration of accu-
mulated Eu(III), relative to untreated cells (Fig. S10C†).
Therefore, the possibility that incubation with SIN-1 and/or
TEMPO promotes efflux of Eu.1 from cells can be ruled out on
the timescale of the experiment.
To conrm that the increase in intracellular ONOO is
responsible for the decrease in emission of Eu.1, a control
experiment was undertaken using probe Eu.Bn, which lacks the
reactive boronic acid moiety. LSCM images, following incuba-
tion of HeLa cells with Eu.Bn (250 mM), revealed a similar
localisation to the mitochondria (Fig. S12A–C†), although
a slightly slower rate of uptake was observed compared with
Eu.1 (maximum uptake at 18 hours, Fig. S11†). Crucially, upon
treatment of Eu.Bn-stained HeLa cells with SIN-1, less than
a 5% decrease in Eu(III) emission intensity was observed, and
the simultaneous addition of SIN-1 and TEMPO induced
a negligible change in emission intensity (Fig. S12D–G†). Thus,
Eu.Bn serves as an effective negative control probe, verifying
that the SIN-1 induced change in luminescence of Eu.1 corre-
sponds to an increase in mitochondrial ONOO levels. Taken
together, these live-cell imaging experiments demonstrate the
powerful potential of Eu.1 for visualising changes in ONOO
concentration within the mitochondria of living cells.
Time-resolved measurement of peroxynitrite in living cells
treated with cold atmospheric plasma
To further demonstrate the biological applications of Eu.1, the
probe was used tomonitor dynamic changes in ONOO levels in
different cell lines, following treatment with a commercially
available cold atmospheric plasma device, kINPEN® MED,
which is used in the clinic for skin wound treatment.10 Plasma
generated NO and ONOO are proposed to interact with
bacterial cell membranes, forming pores that promote further
ingress of RONS. There are multiple mechanisms proposed for
the intracellular formation of ONOO, following plasma treat-
ment.47,48 One mechanism involves plasma generated NO
penetrating cell membranes and combining with O2c
 in the
mitochondria to form ONOO. Therefore, we wished to test the
ability of Eu.1 to selectively visualise intracellular ONOO,
derived from RONS generated externally by the plasma.
First, the expected breakdown of Eu.1 to Eu.8HQ upon
treatment with ionizing plasma was conrmed by HR-TOF
measurements of buffered aqueous samples containing Eu.1
(Fig. S14†), reecting the formation of ONOO in the treated
liquid. Next, Eu.1 (250 mM) was incubated with two different cell
lines, THP and Jurkat cells, for 24 hours. The cells were
centrifuged, washed with 100 mM PBS, and suspended in
a glass bottom 96-well plate. Time-resolved luminescence
spectra of Eu.1 within the cells were recorded using a micro-
plate reader (Fig. S13†).
Samples of each cell line were then treated with cold atmo-
spheric plasma using the kINPen® MED device for 5, 10 and 30
seconds (using an argon gas ow) and the change in time-
resolved luminescence was recorded (Fig. 7A). For both cell
lines, a 75–90% decrease in total emission intensity of Eu.1 was
observed aer 30 seconds, corresponding to a signicant
increase in intracellular ONOO. In THP cells, the emission
intensity had decreased by 45% following 5 seconds treatment,
Fig. 6 LSCM images showing localisation of Eu.1 in the mitochondria
of HeLa cells. (A) Eu.1 only (250 mM, 4 h incubation); (B) MitoTracker
Green™; and (C) merge image (P¼ 0.80). (D) LSCM image of Eu.1 (250
mM, 4 h); (E) Eu.1 (250 mM, 4 h) followed by SIN-1 (500 mM, 30 minute
incubation); and (F) Eu.1 (250 mM, 4 h) following incubation with SIN-1
and TEMPO (500 mM and 1 mM respectively, 30 minute incubation).
3168 | Chem. Sci., 2020, 11, 3164–3170 This journal is © The Royal Society of Chemistry 2020
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whereas Jurkat cells showed a 25% decrease in luminescence
under the same conditions, indicating a lower initial level of
ONOO in Jurkat cells.
To investigate the effect of different plasma gases on the
intracellular concentration of ONOO, 0.5% oxygen and 0.5%
nitrogen was added individually and in combination to the
argon gas ow. THP cells incubated with Eu.1 (250 mM), were
then treated with the kINPen®MED device for 5 and 10 seconds
using the different gas ows (Fig. 7B). The introduction of 0.5%
N2 gas induced a substantial 80% decrease in emission inten-
sity of Eu.1 aer 5 seconds, whereas only a 45% decrease in
luminescence was observed when using argon gas alone. This
correlates with a higher intracellular level of ONOO when
nitrogen is used in the feed gas, consistent with a higher
concentration of NO generated by the plasma. This corresponds
perfectly with the observed modulation of NO generation by
plasmas in pure argon and argon doped with molecular gases,
respectively.49,50 Thus, Eu.1 can be used to visualise elevated
levels of ONOO in different cell lines following extracellular
treatment with a plasma therapy device.
Conclusions
We have developed a robust, water-soluble luminescent euro-
pium(III) probe for the rapid and sensitive detection of ONOO
in living cells. The probe displays excellent selectivity for
ONOO over other RONS, and provides a change in lumines-
cence that is directly proportional to ONOO concentration in
the nanomolar to low micromolar range. The Eu(III) probe offers
advantages over classical organic uorescent probes, including
an instantaneous and long-lived luminescence signal, which
enables time-resolved measurements of ONOO to be under-
taken, avoiding the inuence of autouorescence in biological
samples, thereby enhancing precision and signal-to-noise.
To demonstrate the utility of our probe, a plate reader-based
assay was developed for the quantication of ONOO in human
serum, with minimal interference from other reactive species,
biological cations, anions and protein. The Eu(III) probe was
shown to permeate a range of different cell lines and localise
preferentially to the mitochondria, allowing the presence of
endogenous and/or externally induced ONOO to be monitored
with sub-cellular resolution using uorescence microscopy.
Finally, the Eu(III) probe was applied for the rst time in
monitoring elevated levels of ONOO in living cells, following
treatment with a cold atmospheric plasma device standardised
for clinical applications. The probe design features established
in this work will inform the future development of emissive
Eu(III)/Tb(III) probes, capable of measuring ONOO by providing
a ratiometric signal that is intrinsically normalised, and thus
independent of probe concentration.
In conclusion, the Eu(III) probe can provide valuable insight
into the spatial and temporal distribution of ONOO in cells,
enabling a better understanding of its roles in cell biology and
the mechanisms of transport of RONS into cells. This could
facilitate the development of more effective therapies and
devices, tailored to delivering specic levels of ONOO to tar-
geted sites within cells and enabling safe doses of treatment to
be determined.
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